Table 2.
PFS | OS | |||||
---|---|---|---|---|---|---|
HR | 95%CI | P-value | HR | 95%CI | P-value | |
ECOG PS | ||||||
0 vs. 1 | 0.79 | 0.19 – 3.36 | 0.75 | 0.29 | 0.064 – 1.28 | 0.10 |
No. of organs involved |
||||||
1 vs. ≥2 | 0.86 | 0.49 – 1.52 | 0.60 | 0.47 | 0.20 – 1.08 | 0.074 |
Tumor location | ||||||
Left vs. right | 0.60 | 0.28 – 1.29 | 0.19 | 0.41 | 0.16 – 1.04 | 0.061 |
NLR | ||||||
Low vs. high | 0.55 | 0.31 – 0.95 | 0.033 | 0.44 | 0.20 – 0.96 | 0.038 |
NLR, neutrophil-lymphocyte ratio; PFS, progression-free survival; OS, overall survival